Microbiome-Metabolomics Analysis of the Impacts of Balantidium Coli Infection in Rhesus Monkeys (Macaca mulatta)

Heling Li1,2, Long Zhang3, Faliang Zong2

  • 1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China.

PubMed

Insights

Balantidium coli (B. coli) infection in rhesus monkeys causes significant gut microbiota dysbiosis, altering bacterial populations and decreasing key metabolites. This research suggests microbial interventions as a potential treatment for balantidiosis.

Area of Science:

  • Microbiology
  • Parasitology
  • Metabolomics

Background:

  • Balantidium coli (B. coli) is a common intestinal parasite in monkeys, known to disrupt gut microbiota in pigs.
  • Limited research exists on B. coli's impact on rhesus monkey gut microbiota and metabolites.

Purpose of the Study:

  • To investigate alterations in fecal microbiota and metabolites in rhesus monkeys infected with B. coli.
  • To compare gut microbial composition and metabolic profiles between infected and healthy rhesus monkeys.

Main Methods:

  • Fecal samples from infected and healthy rhesus monkeys analyzed using gene sequencing for microbiota and gas chromatography-mass spectrometry (GC-MS) for metabolites.
  • Statistical analyses (p < 0.05) were employed to identify significant differences.

Main Results:

  • Significant differences in gut microbiota composition observed between infected and healthy monkeys (p < 0.01).
  • Increased abundance of Campylobacterota (p < 0.01) and Prevotella 9 (p < 0.05); decreased Bacteroidota (p < 0.05) and Prevotella copri (p < 0.05).
  • Reduced levels of dihydrolipoamide, 9(Z),11(E)-Conjugated Linoleic Acid, and 8,9-DiHETrE in infected monkeys (p < 0.05).

Conclusions:

  • B. coli colonization is linked to gut microbiota dysbiosis in rhesus monkeys.
  • Findings suggest potential for microbial therapies instead of antibiotics for balantidiosis.
  • Provides a foundation for studying host-protozoa interactions via microbiome-metabolome analysis.